iBio is a developer and provider of product applications for its iBioLaunch and iBioModulator platforms, offering collaborators full support for turnkey implementation of its technology for proprietary and biosimilar products. Complementary to the iBioLaunch platform, the iBioModulator platform enables substantially improved vaccine products with greater potency and duration of effect and can be used with any recombinant expression technology for vaccine development and production. For more information, visit the company’s Web site: http://www.ibioinc.com

Let us hear your thoughts below: